At the fifth Annual General Meeting of Syngenta AG, the 1016 shareholders representing 25.88% of the total shares approved all the motions proposed by the Board of Directors. for Syngenta

Send us Feedback

Syngenta AG (SYT)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

SYT » Topics » At the fifth Annual General Meeting of Syngenta AG, the 1016 shareholders representing 25.88% of the total shares approved all the motions proposed by the Board of Directors.

This excerpt taken from the SYT 6-K filed Apr 21, 2006.

At the fifth Annual General Meeting of Syngenta AG, the 1016 shareholders representing 25.88% of the total shares approved all the motions proposed by the Board of Directors.

Shareholders approved an increase in the dividend of 22 per cent to CHF3.30, to be paid by way of a nominal share value reduction. Shareholders also approved a reduction of the share capital through the cancellation of 2.3 million shares, which the Company had repurchased on a second trading line. The shareholders also authorized the Board to purchase up to 10 per cent of the total share capital. For this purpose, the Company intends to open a new second trading line on virt-x on May 30, 2006, with a term of 3 years.

Dr. Jürg Witmer, Chairman of Givaudan, was elected as a new member of the Board for a three-year term of office. Peggy Bruzelius, Peter Doyle and Pierre Landolt were re-elected to the Board for a three-year term of office.

The annual and financial reports for 2005 were approved. Ernst & Young AG were re-elected as Group Auditors of Syngenta.

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2005 were approximately $8.1 billion. Syngenta employs more than 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at www.syngenta.com.

Media Enquiries:	Switzerland:	Guy Wolff	Tel:	+41 (61) 323 2323
	USA:	Sarah Hull	Tel:	+1 (202) 628 2372
	UK:	Andrew Coker	Tel:	+44 (1344) 41 4503

Analysts/Investors:	Switzerland:	Jonathan Seabrook	Tel:	+41 (61) 323 7502
		Jennifer Gough	Tel:	+41 (61) 323 5059
	USA:	Rhonda Chiger	Tel:	+1 (917) 322 2569

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

Syngenta – April 19, 2006 / Page 1 of 1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		SYNGENTA AG



Date:	April 20, 2006	By:	/s/ Christoph Mäder

			Name:	Christoph Mäder
			Title:	Head Global Legal and Taxes

		By:	/s/ Damian Heller

			Name:	Damian Heller
			Title:	Company Secretary

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Syngenta AG (SYT)

SYT » Topics » At the fifth Annual General Meeting of Syngenta AG, the 1016 shareholders representing 25.88% of the total shares approved all the motions proposed by the Board of Directors.